Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Scrip Team
Executives On The Move: New Responsibilities For Sanofi CMO, A Strategic Promotion At Alexion And A C-Level Resignation At Medivir
To integrate digital and medical, Sanofi’s CMO Ameet Nathwani is now also Chief Digital Officer. Alexion promotes SVP to Chief Strategy and Business Development Officer, and the CFO resigns from Swedish oncology biotech Medivir.
C-suite moves at cancer biotech Geron Corp, EMD Serono Inc and Kiadis Pharma, while German biotech MorphoSys AG names David Trexler as its new president.
Clinical VPs exit Eisai and Pfizer for positions at mRNA product firm CureVac and nanomedicines developer Taiwan Liposome. New chairman and CEO takes the reins at regenerative medicine company Histogen.
Research and clinical are in the spotlight this week with new EVP, R&D leaders at global CNS pharma Lundbeck and gene-based therapeutics firm Sangamo. And Angion Biomedica, a kidney disease biopharma, announces its new SVP, CMO.
Endologix CEO makes a switch to CEO at Vascular Therapies, and Clinical Research and Commercial VPs exit Gilead Sciences. Plus, producer of OTC and generic drugs Perrigo Company appoints EVP, CSO.
GI head departs Takeda for CMO spot at Ironwood Pharmaceuticals, and global head, oncology leaves Roche for CEO role at Tizona Therapeutics.